Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital.

NCT05891964 is registered in ClinicalTrials.gov with Jinnah Postgraduate Medical Centre as lead sponsor.

NCT NCT05891964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05891964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital.
Lead sponsor
Jinnah Postgraduate Medical Centre
Phase
Phase 4
Overall status
Completed
Start date
July 5, 2021
Completion date
July 10, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis